Literature DB >> 15242618

Polo-like kinase-2 is required for centriole duplication in mammalian cells.

Silke Warnke1, Stefan Kemmler, Rebecca S Hames, Hsiao-Lun Tsai, Urs Hoffmann-Rohrer, Andrew M Fry, Ingrid Hoffmann.   

Abstract

Centriole duplication initiates at the G1-to-S transition in mammalian cells and is completed during the S and G2 phases. The localization of a number of protein kinases to the centrosome has revealed the importance of protein phosphorylation in controlling the centriole duplication cycle. Here we show that the human Polo-like kinase 2 (Plk2) is activated near the G1-to-S transition of the cell cycle. Endogenous and overexpressed HA-Plk2 localize with centrosomes, and this interaction is independent of Plk2 kinase activity. In contrast, the kinase activity of Plk2 is required for centriole duplication. Overexpression of a kinase-deficient mutant under S-phase arrest blocks centriole duplication. Downregulation of endogenous Plk2 with small hairpin RNAs interferes with the ability to reduplicate centrioles. Furthermore, centrioles failed to duplicate during the cell cycle of human fibroblasts and U2OS cells after overexpression of a Plk2 dominant-negative mutant. These results show that Plk2 is a physiological centrosomal protein and that its kinase activity is likely to be required for centriole duplication near the G1-to-S phase transition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242618     DOI: 10.1016/j.cub.2004.06.059

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  58 in total

1.  Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication.

Authors:  Hongbo Ling; Lirong Peng; Jianbo Wang; Raneen Rahhal; Edward Seto
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

2.  Centrosome amplification and chromosomal instability in human and animal parthenogenetic cell lines.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Sara Maffei; Gianluca Tettamanti; Arianna Vanelli; Sara Isaac; Amir Eden; Sergio Ledda; Magda de Eguileor; Fulvio Gandolfi
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

3.  PLK2 phosphorylation is critical for CPAP function in procentriole formation during the centrosome cycle.

Authors:  Jaerak Chang; Onur Cizmecioglu; Ingrid Hoffmann; Kunsoo Rhee
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

4.  Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2.

Authors:  Jernej Kristl; Petra Slanc; Metka Krasna; Ales Berlec; Matjaz Jeras; Borut Strukelj
Journal:  Pharm Res       Date:  2007-08-02       Impact factor: 4.200

Review 5.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

Review 6.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

7.  Structural analysis of the polo-box domain of human Polo-like kinase 2.

Authors:  Ju Hee Kim; Bonsu Ku; Kyung S Lee; Seung Jun Kim
Journal:  Proteins       Date:  2015-04-28

Review 8.  Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity.

Authors:  Christopher L Frank; Li-Huei Tsai
Journal:  Neuron       Date:  2009-05-14       Impact factor: 17.173

9.  The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.

Authors:  Elizabeth M Matthew; Lori S Hart; Aristotelis Astrinidis; Arunasalam Navaraj; Nathan G Dolloff; David T Dicker; Elizabeth P Henske; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2009-12-15       Impact factor: 4.534

10.  Over expression of Plk1 does not induce cell division in rat cardiac myocytes in vitro.

Authors:  Carmen H Coxon; Katrina A Bicknell; Fleur L Moseley; Gavin Brooks
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.